Trial intelligence / Profile preview

Ganciclovir PK in patients on CRRT

NCT00264368Phase 4Terminated

Sponsor
University of Oslo School of Pharmacy
Start
Dec 2005
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of ganciclovir in cytomegalovirus infection (CMV), sponsored by University of Oslo School of Pharmacy. Started Dec 2005; status: terminated.

02

Drugs

ganciclovir
03

Conditions

cytomegalovirus infection (CMV)

Beyond the preview

Go deeper on NCT00264368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00264368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call